Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-07-29
2008-07-29
Saeed, Kamal (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S414000, C514S417000, C548S467000, C548S472000, C548S477000
Reexamination Certificate
active
07405237
ABSTRACT:
Novel isoindoline compounds are disclosed. Methods of treating, preventing and/or managing cancer, diseases and disorders associated with, or characterized by, undesired angiogenesis, and diseases and disorders mediated by PDE 4, using the compounds are also disclosed.
REFERENCES:
patent: WO 99/06041 (1999-02-01), None
patent: WO 00/55134 (2000-09-01), None
patent: WO 01/46183 (2001-06-01), None
patent: WO 03/014315 (2003-02-01), None
Sun et al. (Shegwu Huaxue Yu Shegwu Wuli Xuebao 1964, 4(5), 539-50)—CAS Abstract Attached.
El-Naggar et al.,Indian Journal of Chemistry. Section B: Organic, Incl. Medicinal, Publications & Information Directorate, 20B(6): 514-517 (1981).
Man Hon-Wah
Muller George W.
Celgene Corporation
Insogna Anthony
Jones Day
Nolan Jason M
Saeed Kamal
LandOfFree
Isoindoline compounds and methods of their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isoindoline compounds and methods of their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoindoline compounds and methods of their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2813279